Form 4: Astera Labs Director Manuel Alba Sells Shares Under 10b5-1 Trading Plan

Director Manuel Alba of Astera Labs sold shares of common stock on September 20 and 23, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Manuel Alba, a director at Astera Labs, sold shares of the company's common stock on September 20 and 23, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on May 31, 2024.
• On September 20, 2024, Alba sold 12,000 shares at $50 per share and 51,000 shares at a weighted average price of $50.0019.
• On September 23, 2024, Alba sold 7,977 shares at a weighted average price of $50.3146, 23 shares at $51, 28,916 shares at a weighted average price of $50.3146, and 84 shares at $51.
• Following these transactions, Alba directly owns no shares, but indirectly owns 498,863 shares through Casa Alameda 2007, LLC, and 2,234,498 shares through the Alba Trust, and 5,000 shares by spouse.
• Alba disclaims beneficial ownership of the shares held by Casa Alameda 2007, LLC and the Alba Trust, except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating insider trading activity. The sentiment is neutral as it simply reports transactions under a pre-arranged trading plan.

Industry Context

Sales by insiders are a normal part of corporate governance, especially when executed under pre-arranged trading plans like Rule 10b5-1, which allows insiders to sell shares over a period of time without being accused of trading on non-public information.

Stakeholder Impact

• The sale of shares by a director could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates concerns about insider trading based on privileged information.

Key Dates